目的研究早期目标指导(Early goal-directed therapy,EGDT)对感染性多器官功能障碍综合征(manned orbital development station,MODS)的疗效。方法回顾分析我院2012年6月至2015年10月ICU室94例住院患者临床资料作为研究材料,按照治疗方...目的研究早期目标指导(Early goal-directed therapy,EGDT)对感染性多器官功能障碍综合征(manned orbital development station,MODS)的疗效。方法回顾分析我院2012年6月至2015年10月ICU室94例住院患者临床资料作为研究材料,按照治疗方法的不同将其分为对照组和观察组两组,每组47例。其中对照组给予常规治疗,观察组则在常规治疗的基础上辅以EGDT治疗,比较两组患者的治疗效果。结果观察组患者治疗显效的有27例,其治疗总有效率为97.87%,对照组治疗显效的15例、其治疗总有效率为85.11%,观察组治疗有效率显著高于对照组85.11%;观察组患者MODS、SOFA、APACHEⅡ评分均较对照组少;观察组患者治疗后器官衰竭、血小板以及平均动脉压水平均显著优于对照组,差异具有统计学意义(均P<0.05)。结论常规治疗辅以EGDT治疗对于感染性多器官功能障碍综合征的效果更好,能有效缓解感染性MODS的临床症状,预后效果良好,安全性高,值得临床推荐。展开更多
脓毒性休克(Septic shock)是由于全身性感染导致多器官功能受损为特点的一种综合征,是重症加强治疗病房(Intensive care unit, ICU)患者常见的死亡原因之一。脓毒性休克患者的主要临床表现为血流动力学紊乱,因此精确的血流动力学评估和...脓毒性休克(Septic shock)是由于全身性感染导致多器官功能受损为特点的一种综合征,是重症加强治疗病房(Intensive care unit, ICU)患者常见的死亡原因之一。脓毒性休克患者的主要临床表现为血流动力学紊乱,因此精确的血流动力学评估和快速准确的液体复苏对疾病的治疗非常重要。PiCCO即脉搏指示连续性排出量监测(Pulse indicator continuous cardiac output),是一种结合动脉脉搏轮廓连续心排血量监测与经肺热稀释心排血量监测的新型血流动力学监测技术,具有临床操作简单、对患者机体损伤小、参数更直观全面等优点,能更好地指导脓毒性休克患者早期目标导向液体治疗(Early goal directed fluidtherapy, EGDT),减少因过度补液引起的肺水肿和肺部感染加重,减少心功能衰竭的发生,提高液体复苏治疗成功率,有助于患者近期的综合治疗,但对于脓毒性休克患者远期转归无明显改善。展开更多
Objective: To investigate the efficacy and mechanism of EGDT against NPC cell lines. Methods: M'IT assay was used to assess cell proliferation inhibition of EGDT. The apoptotic induction and cell cycle arrest were ...Objective: To investigate the efficacy and mechanism of EGDT against NPC cell lines. Methods: M'IT assay was used to assess cell proliferation inhibition of EGDT. The apoptotic induction and cell cycle arrest were detected by flow cytometry. Western blot was adopted to detect the protein levels. Quantitative Real-time PCR was used to determine the mRNA expressions. The NPC xenografts were established to evaluate the tumor growth inhibition of EGDT. Immunohistochemistry was applied to analyze the EGFR expression in the tumor tissues. Results: EGDT showed proliferation inhibition on the NPC cell, induced G0/G1 phase arrest and cell apop- tosis in vitro. EGDT decreased the protein and mRNA levels of EGFR and its downstream RAF/MEK/ERK and PI3K/AKT pathways in time- and dose-dependent manner. Furthermore, EGDT also showed a sound antitumnr activity in NPC xenograft in vivo. Conclusion: The treatment of EGDT displays EGFR and its mediated downstream signaling pathway block- ade through decreasing the protein and mRNA levels, suggesting a promising strategy in treating human NPC.展开更多
目的探讨中心静动脉血二氧化碳分压差(Pcv—aCO2)和早期乳酸清除率在评估感染性休克患者预后中的临床意义。方法选取2010-01—2013—10收住我院重症医学科的82例经早期目标导向治疗(EGDT)达标的感染性休克患者进行前瞻性观察研究,...目的探讨中心静动脉血二氧化碳分压差(Pcv—aCO2)和早期乳酸清除率在评估感染性休克患者预后中的临床意义。方法选取2010-01—2013—10收住我院重症医学科的82例经早期目标导向治疗(EGDT)达标的感染性休克患者进行前瞻性观察研究,记录入院6hPcv—aCO2及患者入院后第-个24h急性生理学和慢性健康状况评分系统Ⅱ(acute physiology and chronic health evaluationⅡ,APACHEⅡ)评分和全身性感染相关性器官衰竭(SOFA)评分;并记录入院时、人院6h、入院24h动脉血乳酸,计算早期乳酸清除率;以入院6hPcv—aCO2高低分为两组:A组(Pcv—aCO2〈6mmHg)和B组(Pcv—aCO2≥6mmHg),比较两组患者乳酸清除率、SOFA评分及病死率。以6h乳酸清除率高低分为两组:c组(乳酸清除率≤10%)和D组(乳酸清除率〉10%),比较两组患者的28天病死率。根据28天病程转归分为死亡组(32例)和存活组(50例),比较两组患者不同时间动脉血乳酸浓度、APACHEⅡ评分。结果B组较A组乳酸清除率低,SOFA评分及病死率高,入院6hPcv—aCO2与6h乳酸清除率存在负相关(r=-0.324,P=0.003)。D组病死率低于C组(P〈0.05)。存活组APACHEⅡ评分较死亡组高,而入院时、6h、24h动脉血乳酸浓度均低于死亡组(P〈0.05)。结论6hPcv—aC02和6h乳酸清除率可作为判断感染性休克患者预后的指标。展开更多
文摘目的研究早期目标指导(Early goal-directed therapy,EGDT)对感染性多器官功能障碍综合征(manned orbital development station,MODS)的疗效。方法回顾分析我院2012年6月至2015年10月ICU室94例住院患者临床资料作为研究材料,按照治疗方法的不同将其分为对照组和观察组两组,每组47例。其中对照组给予常规治疗,观察组则在常规治疗的基础上辅以EGDT治疗,比较两组患者的治疗效果。结果观察组患者治疗显效的有27例,其治疗总有效率为97.87%,对照组治疗显效的15例、其治疗总有效率为85.11%,观察组治疗有效率显著高于对照组85.11%;观察组患者MODS、SOFA、APACHEⅡ评分均较对照组少;观察组患者治疗后器官衰竭、血小板以及平均动脉压水平均显著优于对照组,差异具有统计学意义(均P<0.05)。结论常规治疗辅以EGDT治疗对于感染性多器官功能障碍综合征的效果更好,能有效缓解感染性MODS的临床症状,预后效果良好,安全性高,值得临床推荐。
基金supported by the Youth Research Project of Health and Family Planning Commission of Fujian Province (2015-2-37)
文摘Objective: To investigate the efficacy and mechanism of EGDT against NPC cell lines. Methods: M'IT assay was used to assess cell proliferation inhibition of EGDT. The apoptotic induction and cell cycle arrest were detected by flow cytometry. Western blot was adopted to detect the protein levels. Quantitative Real-time PCR was used to determine the mRNA expressions. The NPC xenografts were established to evaluate the tumor growth inhibition of EGDT. Immunohistochemistry was applied to analyze the EGFR expression in the tumor tissues. Results: EGDT showed proliferation inhibition on the NPC cell, induced G0/G1 phase arrest and cell apop- tosis in vitro. EGDT decreased the protein and mRNA levels of EGFR and its downstream RAF/MEK/ERK and PI3K/AKT pathways in time- and dose-dependent manner. Furthermore, EGDT also showed a sound antitumnr activity in NPC xenograft in vivo. Conclusion: The treatment of EGDT displays EGFR and its mediated downstream signaling pathway block- ade through decreasing the protein and mRNA levels, suggesting a promising strategy in treating human NPC.
文摘目的探讨中心静动脉血二氧化碳分压差(Pcv—aCO2)和早期乳酸清除率在评估感染性休克患者预后中的临床意义。方法选取2010-01—2013—10收住我院重症医学科的82例经早期目标导向治疗(EGDT)达标的感染性休克患者进行前瞻性观察研究,记录入院6hPcv—aCO2及患者入院后第-个24h急性生理学和慢性健康状况评分系统Ⅱ(acute physiology and chronic health evaluationⅡ,APACHEⅡ)评分和全身性感染相关性器官衰竭(SOFA)评分;并记录入院时、人院6h、入院24h动脉血乳酸,计算早期乳酸清除率;以入院6hPcv—aCO2高低分为两组:A组(Pcv—aCO2〈6mmHg)和B组(Pcv—aCO2≥6mmHg),比较两组患者乳酸清除率、SOFA评分及病死率。以6h乳酸清除率高低分为两组:c组(乳酸清除率≤10%)和D组(乳酸清除率〉10%),比较两组患者的28天病死率。根据28天病程转归分为死亡组(32例)和存活组(50例),比较两组患者不同时间动脉血乳酸浓度、APACHEⅡ评分。结果B组较A组乳酸清除率低,SOFA评分及病死率高,入院6hPcv—aCO2与6h乳酸清除率存在负相关(r=-0.324,P=0.003)。D组病死率低于C组(P〈0.05)。存活组APACHEⅡ评分较死亡组高,而入院时、6h、24h动脉血乳酸浓度均低于死亡组(P〈0.05)。结论6hPcv—aC02和6h乳酸清除率可作为判断感染性休克患者预后的指标。